Louis Boon Selected Research

Louis Boon Research Topics

Disease

58	Neoplasms (Cancer) 06/2022 - 07/2007
47	Inflammation (Inflammations) 01/2022 - 10/2006
31	Infections 01/2022 - 03/2002
12	Asthma (Bronchial Asthma) 11/2020 - 10/2006
10	Atherosclerosis 11/2022 - 02/2010
10	Hypersensitivity (Allergy) 01/2019 - 01/2005
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2008
7	Pneumonia (Pneumonitis) 01/2021 - 01/2016
7	Arthritis (Polyarthritis) 01/2019 - 08/2007
6	Melanoma (Melanoma, Malignant) 04/2022 - 04/2015
6	Glioma (Gliomas) 01/2021 - 07/2007
6	Human Influenza (Influenza) 01/2021 - 08/2009
6	Eosinophilia 10/2018 - 10/2006
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2017 - 08/2002
4	Colitis 01/2020 - 07/2004
4	Neuroblastoma 01/2020 - 03/2014
4	Rheumatoid Arthritis 01/2019 - 08/2006
4	Glioblastoma (Glioblastoma Multiforme) 11/2017 - 02/2014
4	Edema (Dropsy) 01/2017 - 07/2004
4	Insulin Resistance 01/2017 - 02/2007
4	Obesity 10/2014 - 02/2007
3	Peanut Hypersensitivity (Peanut Allergy) 01/2019 - 01/2005
3	Multiple Sclerosis 12/2017 - 08/2002
3	Atherosclerotic Plaque (Atheroma) 03/2016 - 01/2013
3	Thrombosis (Thrombus) 03/2016 - 11/2010
2	Necrosis 11/2022 - 02/2007
2	Mesothelioma 01/2022 - 07/2015
2	Aspergillosis 01/2021 - 05/2012
2	Fibrosis (Cirrhosis) 01/2020 - 02/2010

Drug/Important Bio-Agent (IBA)

36	CytokinesIBA 01/2022 - 10/2006
21	AntigensIBA 01/2022 - 01/2005
20	AntibodiesIBA 04/2022 - 03/2004
13	LigandsIBA 01/2022 - 05/2007
11	VaccinesIBA 01/2022 - 10/2009
11	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2005
9	AllergensIBA 01/2022 - 01/2005
9	Immune Checkpoint InhibitorsIBA 01/2022 - 07/2015
9	Immunoglobulin G (IgG)IBA 10/2018 - 11/2005
9	CD40 Ligand (CD40L)IBA 03/2016 - 03/2004
8	InterferonsIBA 04/2022 - 02/2007
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2006
7	Interleukin-17 (Interleukin 17)IBA 11/2022 - 03/2009
7	AutoantigensIBA 01/2022 - 11/2002
7	Interleukin-10 (Interleukin 10)IBA 01/2020 - 09/2008
7	Peptides (Polypeptides)IBA 01/2018 - 04/2009
6	Monoclonal AntibodiesIBA 01/2022 - 08/2002
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 08/2011
6	Immunoglobulin E (IgE)IBA 10/2018 - 06/2007
5	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2013
5	Messenger RNA (mRNA)IBA 01/2021 - 04/2014
5	chenodeoxycholate sulfate conjugate (CDCS)IBA 11/2020 - 10/2011
5	OligosaccharidesIBA 01/2019 - 04/2010
5	OvalbuminIBA 10/2018 - 11/2009
5	Pharmaceutical PreparationsIBA 01/2018 - 07/2005
5	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2010
5	Polysaccharides (Glycans)IBA 02/2016 - 03/2002
4	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 12/2007
4	Immunoglobulin A (IgA)IBA 01/2022 - 08/2013
4	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2009
4	Interleukin-33IBA 01/2021 - 04/2015
4	IntegrinsIBA 01/2018 - 06/2015
4	Interleukin-4 (Interleukin 4)IBA 01/2018 - 09/2008
4	Therapeutic UsesIBA 03/2015 - 02/2010
4	Transcription Factors (Transcription Factor)IBA 04/2014 - 03/2009
3	Interleukin-23 (Interleukin 23)IBA 11/2022 - 05/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2013
3	CollagenIBA 01/2021 - 06/2015
3	Antiviral Agents (Antivirals)IBA 01/2021 - 08/2009
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2020 - 07/2014
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2020 - 05/2014
3	Histone Deacetylase InhibitorsIBA 01/2020 - 06/2016
3	GlucocorticoidsIBA 01/2020 - 04/2014
3	Vorinostat FDA Link 01/2020 - 06/2016
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2019 - 02/2016
3	InterleukinsIBA 07/2017 - 02/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 05/2013
3	Insulin (Novolin)FDA Link 01/2017 - 02/2007
3	Interleukin-12 (IL 12)IBA 01/2016 - 10/2006
3	Interleukin-2 (IL2)IBA 03/2015 - 02/2012
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2022 - 01/2018
2	Proto-Oncogene Proteins c-hckIBA 06/2022 - 01/2020
2	src-Family KinasesIBA 06/2022 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 06/2022 - 01/2022
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
2	Lipocalin-2IBA 01/2021 - 08/2013
2	Biological ProductsIBA 12/2020 - 05/2008
2	Granzymes (Granzyme)IBA 01/2020 - 01/2016
2	CarcinogensIBA 01/2020 - 01/2017
2	Fc Receptors (Fc Receptor)IBA 01/2020 - 06/2016
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2014
2	Phosphotransferases (Kinase)IBA 11/2019 - 06/2015
2	HMGB1 Protein (HMG1)IBA 11/2019 - 03/2015
2	CarbohydratesIBA 01/2019 - 01/2012

Therapy/Procedure

35	Therapeutics 04/2022 - 05/2009
28	Immunotherapy 06/2022 - 07/2007
4	Drug Therapy (Chemotherapy) 01/2022 - 02/2015
3	Oncolytic Virotherapy 07/2021 - 01/2017
2	Radiotherapy 01/2021 - 03/2015
2	Photochemotherapy (Photodynamic Therapy) 06/2020 - 06/2016